DowDuPont
DDNYSEOther · Plastic Materials, Synth Resins & Nonvulcan Elastomers · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.61B | $1.60B | $6.61B | $13.02B | $12.57B | $11.13B |
| Operating income | — | — | — | — | — | — |
| Net income | −$589.0M | $188.0M | $423.0M | $5.87B | $6.47B | −$2.95B |
| Total assets | $21.57B | $36.64B | $38.55B | $41.35B | $45.71B | $70.90B |
| Total liabilities | $7.47B | $12.84B | $13.83B | $14.34B | $18.66B | $31.83B |
| Equity | $13.92B | $23.35B | $24.28B | $26.57B | $26.43B | $38.50B |
| EPS (diluted) | $-1.40 | $0.44 | $0.94 | $11.75 | $11.89 | $-4.01 |
| Shares out. | 418.0M | 417.6M | 458.3M | 512.9M | 538.1M | 739.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- −36.5%
- Return on equity
- −4.2%
- Return on assets
- −2.7%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 34.6%
- Debt / equity
- 0.54×
- Book value / share
- $33.30
- Revenue growth (YoY)
- 0.8%
- Net income growth (YoY)
- −413.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −5.3%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 4 good- Reported a net loss
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Macpherson Donald GDirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Breen Edward DDirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Mcmaken Kurt BDirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Lowery Frederick M.Director | May 21, 2026 | Grant | 4,030 | $0.00 |
| Lico James ADirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Du Pont Eleuthere IDirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Cutler Alexander MDirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Chandy Ruby RDirector | May 21, 2026 | Grant | 4,030 | $0.00 |
| Brady Amy G.Director | May 21, 2026 | Grant | 4,030 | $0.00 |
| Breen Edward DDirector | May 4, 2026 | Tax withholding | 11,538.158 | $45.54 |
| Franzen Antonella BOfficer — SVP & CFO | May 4, 2026 | Tax withholding | 245.836 | $45.54 |
| Hoover Erik T.Officer — SVP & General Counsel | May 4, 2026 | Tax withholding | 1,525.684 | $45.54 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 11.9M | 2.6 | +15.1% |
| Apr 30, 2026 | 10.4M | 3.5 | +0.9% |
| Apr 15, 2026 | 10.3M | 3.5 | -5.4% |
| Mar 31, 2026 | 10.8M | 2.5 | +46.2% |
| Mar 13, 2026 | 7.4M | 1.7 | -14.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder vote · Regulation FD disclosureMay 26, 2026
- Results of operationsMay 5, 2026
- Director / officer changeApr 15, 2026
- Other material eventMar 18, 2026
- Regulation FD disclosureMar 16, 2026
- Results of operationsFeb 10, 2026
- Director / officer changeJan 20, 2026
- Other material eventDec 4, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spin-offs from DowDuPont (2)
- Corteva, Inc.CTVAcompletedJun 1, 2019details
- DOW INC.DOWcompletedMar 31, 2019details
From the spin-off filings we track. Follow a company to walk its own history.